Asunción Morán

Dr. Asunción Morán


Research Focus & Metrics

Academic Career Length

40Years (1987-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 August 2013 in European Journal of Pharmacology
Verified
Journal Article
Closed access
JGJose-Ángel García-Pedraza
Jose-Ángel García-Pedraza
MGMónica García-Domingo
Mónica García-Domingo
MMMaría Luisa Martín
María Luisa Martín
JGJesús Gómez-Escudero
Jesús Gómez-Escudero
ARAlicia Rodríguez-Barbero
Alicia Rodríguez-Barbero
AMAsunción Morán
Asunción Morán

1 December 1994 in British Journal of Pharmacology
Verified
Journal Article
Open access
PDF file
AMAsunción Morán
Asunción Morán
CVC. Velasco
C. Velasco
TST. Salvador
T. Salvador
MMM.L. Martín
M.L. Martín
LRL. San Román
L. San Román
1 A study was made of the effects of 5-hydroxytryptamine (5-HT) on pressor response induced in vivo by electrical stimulation of the sympathetic outflow from the spinal cord of pithed rats. All animals had been pretreated with atropine. Intravenous infusion of 5-hydroxytryptamine at doses of 10 and 20 μg kg−1 min−1 reduced the pressor effects obtained by electrical stimulation at intervals of 10 min over the 1 h of infusion. 2 This inhibitory action of 5-HT was depressed by cyproheptadine and methiothepin but was not modified by ketanserin or MDL-72222. By contrast, the inhibitory action of 5-HT was lost in pithed rats that had been pretreated with exogenous noradrenaline. 3 The 5-HT1 receptor agonist 5-carboxamidotryptamine (5-CT) caused an inhibition of the pressor response, whereas the 5-HT3 receptor agonist, 1-phenylbiguanide, produced a variable but significant increase in the pressor response. The 5-HT2 receptor agonist, m-CPP, did not modify the pressor sympathetic response. 4 Our results suggest that 5-hydroxytryptamine interferes with sympathetic neurotransmission by inhibiting pressor effects as a result of stimulation of the complete sympathetic outflow, and that this inhibition is mainly through a presynaptic 5-HT1 mechanism.

1 April 1999 in Life Sciences
Verified
Journal Article
Closed access
CVCarlos M. Villalón
Carlos M. Villalón
David CenturiónDavid Centurión
David Centurión
MGMar Fernandez Gutierrez
Mar Fernandez Gutierrez
AMAsunción Morán
Asunción Morán
ASAraceli Sánchez-López
Araceli Sánchez-López

1 February 1994 in European Journal of Pharmacology
Verified
Journal Article
Closed access
AMAsunción Morán
Asunción Morán
CVCristina Velasco
Cristina Velasco
MMMaria-Luisa Martín
Maria-Luisa Martín
LRLuis San Román
Luis San Román

1 April 1989 in Journal of Ethnopharmacology
Verified
Journal Article
Closed access
AUA.V.Ortiz de Urbina
A.V.Ortiz de Urbina
MMM.L. Martín
M.L. Martín
MMM.J. Montero
M.J. Montero
AMAsunción Morán
Asunción Morán
LRL.San Román
L.San Román

1 April 1997 in Journal of Pharmacy and Pharmacology
Verified
Journal Article
Closed access
PDF file
AMAsunción Morán
Asunción Morán
EMElena Martín
Elena Martín
CVCristina Velasco
Cristina Velasco
MMM. Luisa Martín
M. Luisa Martín
LRLuis San Roman
Luis San Roman
AFArturo San Feliciano
Arturo San Feliciano